Keywords :
Cost of Illness; Humans; Muscular Atrophy, Spinal/therapy; Patient Participation; Quality Improvement; Quality of Life; Adults living with SMA; Burden of Disease (BoD); Neuromuscular Disease (NMD); Quality of Life (QoL); Spinal Muscular Atrophy (SMA); health services; lived experience; transition
Abstract :
[en] While Spinal Muscular Atrophy (SMA) has historically been managed with supportive measures, the emergence of innovative medicines has given those living with SMA hope for improved quality of life and has revolutionized care. Despite these advances, the use of therapies and changes in disease management strategies have focused on pediatric populations, leaving adults living with SMA, and those transitioning into adulthood, relatively neglected. Through a multi-faceted approach that gathered unbiased perspectives from clinical experts, validated insights from individuals with lived experiences, and substantiated findings with evidence from the literature, we have exposed unmet needs that are hindering the field and, ultimately, impacting care and quality of life for adults living with SMA. Here, we set new aspirations and calls to action to inspire continued research in this field, stimulate dialogue across the SMA community and inform policies that deliver effective management and care throughout an adult's journey living with SMA.
Scopus citations®
without self-citations
3